Nom du produit:(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-amine
IUPAC Name:(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-amine
- CAS：2364560-36-9
- Formule moléculaire：C13H15N3O
- Pureté：95%+
- Numéro de catalogue：CM1046485
- Poids moléculaire：229.28
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2364560-36-9
- Formule moléculaire:C13H15N3O
- Point de fusion:-
- Code SMILES:C(C)C1=NC(C=2C=C3C(=CC2)[C@H](N)CC3)=NO1
- Densité:
- Numéro de catalogue:CM1046485
- Poids moléculaire:229.28
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Oxadiazoles
- Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.
Column Infos
- Aficamten
- Evaluate Pharma recently issued an article listing "the most valuable potential drugs currently under development", and Aficamten is one of them. Aficamten is a novel cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy, which achieves its therapeutic effect by reducing the hypercontractility of obstructive HCM and improving diastolic function.
Recherche 
+86 21 5895 0110 
